Highlights
LSE: SHP       SHIRE PLC ORD 5P
Last Price Today's Change   Day's Range   Trading Volume
3,820.00   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):5,195,013
4 Weeks Range:3,530.50 - 4,090.50
4 Weeks Price Volatility (%):
93.39%
52 Weeks Range:2,940.50 - 5,021.00
52 Weeks Price Volatility (%):
76.08%
Average Price Target: 5,300.00
Price Target Upside/Downside: +1,480.00

Headlines

Date Subject
13-Sep-2017 Wednesday broker round-up
05-Sep-2017 Tuesday broker round-up
11-Aug-2017 Friday broker round-up
06-Jul-2017 Thursday broker round-up
28-Jun-2017 Wednesday broker round-up
27-Jun-2017 Tuesday broker round-up
09-Jun-2017 Friday broker round-up
19-May-2017 Friday broker round-up
17-May-2017 Wednesday broker round-up
10-May-2017 Wednesday broker round-up
04-May-2017 Thursday broker round-up
03-May-2017 Wednesday broker round-up

Business Background

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).

  Be the first to like this.
 


 

10120 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 XFVT 2,538.500.00 
 BRIC 2,312.000.00 
 DC 199.550.00 
 BAKK 188.000.00 
 FFI 72.500.00 
Partners & Brokers